Type 2 inflammation in asthma and other airway diseases

医学 免疫学 美波利祖马布 奥马佐单抗 先天性淋巴细胞 苯拉唑马布 哮喘 白细胞介素13 哮喘的病理生理学 炎症 免疫球蛋白E 免疫系统 过敏性炎症 嗜酸性粒细胞 先天免疫系统 白细胞介素4 抗体
作者
Jorge Máspero,Yochai Adir,Mona Al‐Ahmad,C.A. Celis-Preciado,Federico D. Colodenco,Pedro Giavina‐Bianchi,Hani Lababidi,Olivier Ledanois,Bassam Mahoub,Diahn‐Warng Perng,Juan Carlos Vázquez-García,Arzu Yorgancıoğlu
出处
期刊:ERJ Open Research [European Respiratory Society]
卷期号:8 (3): 00576-2021 被引量:113
标识
DOI:10.1183/23120541.00576-2021
摘要

Chronic inflammatory airway diseases, including asthma, chronic rhinosinusitis, eosinophilic COPD and allergic rhinitis are a global health concern. Despite the coexistence of these diseases and their common pathophysiology, they are often managed independently, resulting in poor asthma control, continued symptoms and poor quality of life. Understanding disease pathophysiology is important for best treatment practice, reduced disease burden and improved patient outcomes. The pathophysiology of type 2 inflammation is driven by both the innate immune system triggered by pollutants, viral or fungal infections involving type 2 innate lymphoid cells (ILC2) and the adaptive immune system, triggered by contact with an allergen involving type 2 T-helper (Th2) cells. Both ILC2 and Th2 cells produce the type-2 cytokines (interleukin (IL)-4, IL-5 and IL-13), each with several roles in the inflammation cascade. IL-4 and IL-13 cause B-cell class switching and IgE production, release of pro-inflammatory mediators, barrier disruption and tissue remodelling. In addition, IL-13 causes goblet-cell hyperplasia and mucus production. All three interleukins are involved in trafficking eosinophils to tissues, producing clinical symptoms characteristic of chronic inflammatory airway diseases. Asthma is a heterogenous disease; therefore, identification of biomarkers and early targeted treatment is critical for patients inadequately managed by inhaled corticosteroids and long-acting β-agonists alone. The Global Initiative for Asthma guidelines recommend add-on biological (anti IgE, IL-5/5R, IL-4R) treatments for those not responding to standard of care. Targeted therapies, including omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab and tezepelumab, were developed on current understanding of the pathophysiology of type 2 inflammation. These therapies offer hope for improved management of type 2 inflammatory airway diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
AYING完成签到,获得积分10
刚刚
刚刚
vali完成签到,获得积分10
1秒前
乖猫要努力应助graper2010采纳,获得10
1秒前
2秒前
2秒前
熠熠畅发布了新的文献求助10
2秒前
hay关闭了hay文献求助
2秒前
2秒前
万里长城发布了新的文献求助10
3秒前
4秒前
4秒前
5秒前
5秒前
隐形曼青应助cybbbbbb采纳,获得10
5秒前
元谷雪发布了新的文献求助10
6秒前
6秒前
6秒前
雪雪儿发布了新的文献求助10
7秒前
AYING发布了新的文献求助10
7秒前
浮黎原始天尊完成签到,获得积分10
7秒前
8秒前
8秒前
Lin完成签到,获得积分10
8秒前
8秒前
golfgold发布了新的文献求助10
8秒前
Jake发布了新的文献求助20
9秒前
科研F5完成签到,获得积分10
9秒前
9秒前
10秒前
10秒前
不懈奋进应助朱建勋采纳,获得30
10秒前
虚幻的黄蜂完成签到 ,获得积分10
10秒前
善学以致用应助小狗味儿采纳,获得10
11秒前
Slide完成签到 ,获得积分20
12秒前
12秒前
12秒前
13秒前
ZSUGA发布了新的文献求助30
14秒前
Lucas应助Cici采纳,获得10
14秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971216
求助须知:如何正确求助?哪些是违规求助? 3515911
关于积分的说明 11180016
捐赠科研通 3251003
什么是DOI,文献DOI怎么找? 1795626
邀请新用户注册赠送积分活动 875937
科研通“疑难数据库(出版商)”最低求助积分说明 805207